Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Istituto Marangoni Dubai hosted an exclusive press preview showcasing the work of its first graduating cohort in Fashion Design & Accessories. The presentation marks an important milestone for the university since its opening in 2022, offering media and industry guests an intimate view of the emerging talent shaping the next chapter of the institution’s creative community. The showcase […] The post Istituto Marangoni Dubai presents the first graduating cohort of Fashion Design students in an exclusive press preview showcase appeared first on Web-Release.